Ocular Therapeutix, Inc.

This large, late-stage study is testing a tiny, slow-dissolving implant placed in the eye to see if it can safely stop or reverse damage from diabetic retinopathy. It will compare the new implant to a mock injection procedure in about 930 adults with moderate to severe non-prolif…